Search This Blog

Wednesday, June 29, 2022

Avadel: Pursuing strategies to accelerate final approval of FT218 NDA

 

  • Optimizing cost structure to fund strategic priorities and extend cash runway

  • Continuing key activities to accelerate launch timing of FT218, targeting multi-billion-dollar narcolepsy market opportunity

  • Management to host a conference call tomorrow, June 30 at 8:00 a.m. ET

To access the conference call, investors are invited to dial (844) 388-0559 (U.S. and Canada) or (216) 562-0393 (International). The conference ID number is 4176205. A live audio webcast can be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.